Generation of precursor cell lines from preneoplastic fields surrounding head and neck cancers

Head and Neck

Volumn 35, Issue 4, 2013, Pages 568-574

  Van Zeeburg, Hester J T ^a   Graveland, A Peggy ^a   Brink, Arjen ^a   Nguyen, Melanie ^a   Leemans, C René ^a   Bloemena, Elisabeth ^b,c   Braakhuis, Boudewijn J M ^a   Brakenhoff, Ruud H ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

allelic loss; field cancerization; HNSCC; preneoplastic

Indexed keywords

ADULT; AGED; ARTICLE; CELL CULTURE; CELL IMMORTALIZATION; CLINICAL ARTICLE; GENETIC ANALYSIS; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; PRIMARY TUMOR; PRIORITY JOURNAL;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SEPARATION; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MUCOUS MEMBRANE; MUTATION; NEOPLASTIC STEM CELLS; PRECANCEROUS CONDITIONS;

EID: 84875382176     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23004     Document Type: Article

References (30)

1. Braakhuis BJ, Visser O, Leemans CR,. Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: increasing incidence, but not in young adults. Oral Oncol 2009; 45: e85-e89.
2. van Zeeburg HJ, Snijders PJ, Pals G, et al. Generation and molecular characterization of head and neck squamous cell lines of Fanconi anemia patients. Cancer Res 2005; 65: 1271-1276.
3. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH,. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003; 63: 1727-1730.
4. Leemans CR, Braakhuis BJ, Brakenhoff RH,. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11: 9-22.
5. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, et al. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 2002; 161: 1051-1060.
6. Bremmer JF, Braakhuis BJ, Brink A, et al. Comparative evaluation of genetic assays to identify oral pre-cancerous fields. J Oral Pathol Med 2008; 37: 599-606.
7. Rosin MP, Cheng X, Poh C, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 2000; 6: 357-362.
8. Tabor MP, Brakenhoff RH, van Houten VM, et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res 2001; 7: 1523-1532.
9. Schaaij-Visser TB, Graveland AP, Gauci S, et al. Differential proteomics identifies protein biomarkers that predict local relapse of head and neck squamous cell carcinomas. Clin Cancer Res 2009; 15: 7666-7675.
10. Tabor MP, Braakhuis BJ, van der Wal JE, et al. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx. J Pathol 2003; 199: 354-360.
11. Rudin CM, Cohen EE, Papadimitrakopoulou VA, et al. An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia. J Clin Oncol 2003; 21: 4546-4552.
12. Hunter KD, Thurlow JK, Fleming J, et al. Divergent routes to oral cancer. Cancer Res 2006; 66: 7405-7413.
13. Gaballah K, Hills A, Curiel D, Hallden G, Harrison P, Partridge M,. Lysis of dysplastic but not normal oral keratinocytes and tissue-engineered epithelia with conditionally replicating adenoviruses. Cancer Res 2007; 67: 7284-7294.
14. McGregor F, Muntoni A, Fleming J, et al. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine. Cancer Res 2002; 62: 4757-4766.
15. Dickson MA, Hahn WC, Ino Y, et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 2000; 20: 1436-1447.
16. Lee G, Park BS, Han SE, et al. Concurrence of replicative senescence and elevated expression of p16(INK4A) with subculture-induced but not calcium-induced differentiation in normal human oral keratinocytes. Arch Oral Biol 2000; 45: 809-818.
17. Spiekstra SW, Toebak MJ, Sampat-Sardjoepersad S, et al. Induction of cytokine (interleukin-1 alpha and tumor necrosis factor-alpha) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure. Exp Dermatol 2005; 14: 109-116.
18. Brenner JC, Graham MP, Kumar B, et al. Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines. Head Neck 2010; 32: 417-426.
19. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Kummer JA, Leemans CR, Braakhuis BJ,. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. Clin Cancer Res 2004; 10: 3607-3613.
20. Bremmer JF, Graveland AP, Brink A, et al. Screening for oral precancer with noninvasive genetic cytology. Cancer Prev Res (Phila) 2009; 2: 128-133.
21. Tabor MP, van Houten VM, Kummer JA, et al. Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 Gene. Genes Chromosomes Cancer 2002; 33: 168-177.
22. Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007; 121: 2465-2472.
23. Klaassen I, Brakenhoff RH, Smeets SJ, Snow GB, Braakhuis BJ,. Enhanced turnover of all-trans-retinoic acid and increased formation of polar metabolites in head and neck squamous cell carcinoma lines compared with normal oral keratinocytes. Clin Cancer Res 2001; 7: 1017-1025.
24. van Zeeburg HJT, van Beusechem VW, Huizenga A, et al. Adenovirus retargeting to surface expressed antigens on oral mucosa. J Gene Med 2010; 12: 365-376.
25. Reid CB, Cloos J, Snow GB, Braakhuis BJ,. A simple and reliable technique for culturing of human oral keratinocytes and fibroblasts. Acta Otolaryngol 1997; 117: 628-633.
26. Oda D, Bigler L, Lee P, Blanton R,. HPV immortalization of human oral epithelial cells: a model for carcinogenesis. Exp Cell Res 1996; 226: 164-169.
27. Kubo C, Tsutsui TW, Tamura Y, Kumakura S, Tsutsui T,. Immortalization of normal human gingival keratinocytes and cytological and cytogenetic characterization of the cells. Odontology 2009; 97: 18-31.
28. Schaaij-Visser TB, Brakenhoff RH, Jansen JW, et al. Comparative proteome analysis to explore p53 pathway disruption in head and neck carcinogenesis. J Proteomics 2009; 72: 803-814.
29. Smeets SJ, van der Plas M, Schaaij-Visser TB, et al. Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways. Int J Cancer 2011; 128: 1596-1605.
30. Mendelsohn MG, Dilorenzo TP, Abramson AL, Steinberg BM,. Retinoic acid regulates, in vitro, the two normal pathways of differentiation of human laryngeal keratinocytes. In Vitro Cell Devel Biol 1991; 27A: 137-141.